I build aiomics, use AI in my own work and examine how it changes responsibility, professions and competition.
As founder and CEO of aiomics, I work with my team on AI for medical documentation and its verification. I encounter change through building the technology, using AI myself and making decisions as an employer. When tasks become faster, we have to reconsider who takes responsibility and what a good result looks like.
An experienced executive assistant used AI and our company knowledge to prepare most of an application seeking one million euros in funding. I now take on product-design and organisational work that previously depended more heavily on specialists. These experiences make a wider question concrete: how do expertise and the contribution one person can make change?
I studied medicine at Saarland University, followed by public health at the London School of Hygiene & Tropical Medicine, public policy at the University of Oxford and entrepreneurship at the University of Cambridge. Those perspectives help me connect individual decisions with their organisational consequences.
Previously, I was an equity partner and Chief Medical Officer at FoundersLane and a founding-team member of smart Helios. I advise NORD Holding and Speedinvest, and I invest personally. That gives me a view of company development from both the founder’s and investor’s side.
Healthcare is a demanding setting in which to examine these questions. Daily conversations with physicians show how closely good results depend on knowledge, trust and responsibility. My talks connect those lessons to the decisions the audience faces. Building aiomics remains my main focus; speaking creates conversations with potential customers, partners and other founders.
These earlier contributions and conversations provide context. Each entry identifies its publication date and the kind of contribution.
EU-Startups · Company reporting · · Source language: English
Reporting on the September 2025 financing round, the founding team and the planned use of the funds.
Sifted · Authored contribution · · Source language: English
A coauthored contribution about comparing companies through customer needs and the market in which they compete.
The title, byline and excerpts were checked. The full text may require a subscription.
Bitkom · Event retrospective · Undated · Source language: German
Bitkom lists Sven Jungmann as aiomics founder and chief executive for an AI applications session and a discussion of implementation. The event took place in Berlin on 10 June 2026.
The event date is stated; the retrospective has no publication date.
Sven Jungmann
For people responsible for adopting and evaluating AI in their organisation. The book connects the foundations of the technology with judgment, organisational knowledge, economic assessment and responsibility for implementation.
Sven Jungmann
For patients and relatives who want to use AI when exploring health questions. The book considers how to understand findings and medical letters, prepare consultations and develop questions for shared decisions.
Selected by Handelsblatt. The University of Oxford reported the recognition of his work with health data.
University of Oxford announcementAwarded to Halitus, the diagnostics company Sven co-founded, for its approach to AI-assisted breath analysis.
Award recipients at NovartisTell me about your audience, occasion and timing. We can shape a talk around the questions that matter to them.